Cargando…

CLDN10 is Associated with Papillary Thyroid Cancer Progression

The incidence of thyroid cancer is staying at a high level. Claudin family is a skelemin contacting with the intercellular junction and can keep a dynamic balance between cells. Recently, many types of research indicated that the expression level of claudins is closely related to various cancer type...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yili, Xiang, Jingjing, Bhandari, Adheesh, Guan, Yaoyao, Xia, Erjie, Zhou, Xiaofen, Wang, Yinghao, Wang, Ouchen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299396/ https://www.ncbi.nlm.nih.gov/pubmed/30588256 http://dx.doi.org/10.7150/jca.28636

Ejemplares similares

LINC00511 influences cellular proliferation through cyclin-dependent kinases in papillary thyroid carcinoma
por: Xiang, Jingjing, et al.
Publicado: (2020)

PSD3 is an oncogene that promotes proliferation, migration, invasion, and G1/S transition while inhibits apoptotic in papillary thyroid cancer
por: Jin, Lingli, et al.
Publicado: (2021)

CITED1 gene promotes proliferation, migration and invasion in papillary thyroid cancer
por: Xia, Erjie, et al.
Publicado: (2018)

SYT12 is a novel oncogene that promotes thyroid carcinoma progression and metastasis
por: Jin, Lingli, et al.
Publicado: (2021)

lncRNA LINC00673 induces proliferation, metastasis and epithelial-mesenchymal transition in thyroid carcinoma via Kruppel-like factor 2
por: Xia, Erjie, et al.
Publicado: (2018)

ITGA7 functions as a tumor suppressor and regulates migration and invasion in breast cancer
por: Bhandari, Adheesh, et al.
Publicado: (2018)

Synaptopodin-2 plays an important role in the metastasis of breast cancer via PI3K/Akt/mTOR pathway
por: Xia, Erjie, et al.
Publicado: (2018)

Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines
por: Guan, Yaoyao, et al.
Publicado: (2019)

LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in papillary thyroid carcinoma
por: Shen, Yanyan, et al.
Publicado: (2018)

Immortalization up‐regulated protein promotes tumorigenesis and inhibits apoptosis of papillary thyroid cancer
por: Lin, Lizhi, et al.
Publicado: (2020)

Immune-related key gene CLDN10 correlates with lymph node metastasis but predicts favorable prognosis in papillary thyroid carcinoma
por: Xiang, Zhaolan, et al.
Publicado: (2020)

Upregulated LAMB3 increases proliferation and metastasis in thyroid cancer
por: Wang, Yinghao, et al.
Publicado: (2017)

The ETNK2 gene promotes progression of papillary thyroid carcinoma through the HIPPO pathway
por: Zheng, Danni, et al.
Publicado: (2022)

KCNN4 is a diagnostic and prognostic biomarker that promotes papillary thyroid cancer progression
por: Wen, Jialiang, et al.
Publicado: (2020)

Monocyte-to-High-Density Lipoprotein Cholesterol Ratio Together With the Lymphocyte-to-Monocyte Ratio in Predicting the Malignancy of the Thyroid Nodule in Patients Complicated With Type 2 Diabetes
por: Hu, Yingying, et al.
Publicado: (2023)

Aberrant expression of WDR4 affects the clinical significance of cancer immunity in pan-cancer
por: Zeng, Hanqian, et al.
Publicado: (2021)

COPB2 is up‐regulated in breast cancer and plays a vital role in the metastasis via N‐cadherin and Vimentin
por: Bhandari, Adheesh, et al.
Publicado: (2019)

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients
por: Jin, Langping, et al.
Publicado: (2016)

P110α inhibitor alpelisib exhibits a synergistic effect with pyrotinib and reverses pyrotinib resistant in HER2+ breast cancer
por: Chen, Hao, et al.
Publicado: (2023)

Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma
por: Zhang, Zhenfa, et al.
Publicado: (2013)

The IL1β-HER2-CLDN18/CLDN4 axis mediates lung barrier damage in ARDS
por: Ma, Xinhua, et al.
Publicado: (2020)

Downregulation of Immortalization-Upregulated Protein Suppresses the Progression of Breast Cancer Cell Lines by Regulating Epithelial–Mesenchymal Transition
por: Wen, Jialiang, et al.
Publicado: (2020)

Association of CLDN6 and CLDN10 With Immune Microenvironment in Ovarian Cancer: A Study of the Claudin Family
por: Gao, Peipei, et al.
Publicado: (2021)

Genetic landscape of breast cancer and mutation tracking with circulating tumor DNA in Chinese women
por: Wang, Yinghao, et al.
Publicado: (2021)

The Expression of CLDN6 in Hepatocellular Carcinoma Tissue and the Effects of CLDN6 on Biological Phenotypes of Hepatocellular Carcinoma Cells
por: Lu, Yan, et al.
Publicado: (2021)

Lipase member H is a downstream molecular target of hypoxia inducible factor-1α and promotes papillary thyroid carcinoma cell migration in BCPAP and KTC-1 cell lines
por: Li, Yuefeng, et al.
Publicado: (2019)

CUX2 functions as an oncogene in papillary thyroid cancer
por: Sun, Yihan, et al.
Publicado: (2018)

Original tumour suppressor gene polycystic kidney and hepatic disease 1-like 1 is associated with thyroid cancer cell progression
por: Zheng, Chen, et al.
Publicado: (2019)

SPTBN2 Promotes the Progression of Thyroid Cancer by Accelerating G1/S Transition and Inhibiting Apoptosis
por: Zhou, Xiaofen, et al.
Publicado: (2022)

Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs
por: Zeng, Hanqian, et al.
Publicado: (2021)

Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial‐mesenchymal transition
por: Zheng, Chen, et al.
Publicado: (2020)

MicroRNA-142-5p contributes to Hashimoto’s thyroiditis by targeting CLDN1
por: Zhu, Jin, et al.
Publicado: (2016)

Retrospective analysis of prognostic factors in patients of papillary thyroid microcarcinoma
por: Xiang, Tinghai, et al.
Publicado: (2018)

TROP2 modulates the progression in papillary thyroid carcinoma
por: Sun, Huali, et al.
Publicado: (2021)

Pan-cancer analysis of the prognostic and immunological role of PSMB8
por: Chen, Danxiang, et al.
Publicado: (2021)

Analysis of the expression and genetic alteration of CLDN18 in gastric cancer
por: Li, Jian, et al.
Publicado: (2020)

CLDN1 expression in cervical cancer cells is related to tumor invasion and metastasis
por: Zhang, Wei-na, et al.
Publicado: (2016)

Novel strategy of stents in thyroid mass: a case series report of managing severely dyspneic patients
por: Bhandari, Adheesh, et al.
Publicado: (2017)

TTK is a potential regulator of tumor progression correlated with dedifferentiation and immune cell infiltration in papillary thyroid cancer
por: Ma, Jun-Jie, et al.
Publicado: (2023)

Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications
por: Kwon, Mi Jeong, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fc564cpkhpalfk522tr2nqjd5n